CN109207427B - 一种将人造血祖细胞转变为造血干细胞的方法 - Google Patents
一种将人造血祖细胞转变为造血干细胞的方法 Download PDFInfo
- Publication number
- CN109207427B CN109207427B CN201811084025.9A CN201811084025A CN109207427B CN 109207427 B CN109207427 B CN 109207427B CN 201811084025 A CN201811084025 A CN 201811084025A CN 109207427 B CN109207427 B CN 109207427B
- Authority
- CN
- China
- Prior art keywords
- cells
- cord blood
- hematopoietic stem
- progenitor cells
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000003958 hematopoietic stem cell Anatomy 0.000 title claims abstract description 84
- 238000000034 method Methods 0.000 title claims abstract description 14
- 101000980898 Homo sapiens Cell division cycle-associated protein 4 Proteins 0.000 title claims abstract description 11
- 102000044493 human CDCA4 Human genes 0.000 title claims abstract description 11
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims abstract description 49
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims abstract description 49
- 210000004700 fetal blood Anatomy 0.000 claims abstract description 38
- 210000004027 cell Anatomy 0.000 claims abstract description 28
- 230000009466 transformation Effects 0.000 claims abstract description 11
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 claims abstract description 8
- 238000012258 culturing Methods 0.000 claims abstract description 5
- 238000010899 nucleation Methods 0.000 claims abstract description 5
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 claims abstract description 4
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 claims abstract description 4
- 239000000725 suspension Substances 0.000 claims abstract description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 16
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 13
- 239000002609 medium Substances 0.000 claims description 9
- 210000000130 stem cell Anatomy 0.000 claims description 9
- 210000004369 blood Anatomy 0.000 claims description 8
- 239000008280 blood Substances 0.000 claims description 8
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims description 7
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 239000002504 physiological saline solution Substances 0.000 claims description 6
- 238000001179 sorption measurement Methods 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 210000005087 mononuclear cell Anatomy 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- 239000008188 pellet Substances 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 239000011324 bead Substances 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- 210000003743 erythrocyte Anatomy 0.000 claims description 3
- 210000004698 lymphocyte Anatomy 0.000 claims description 3
- 101100220044 Homo sapiens CD34 gene Proteins 0.000 claims description 2
- 239000003146 anticoagulant agent Substances 0.000 claims description 2
- 229940127219 anticoagulant drug Drugs 0.000 claims description 2
- 239000002577 cryoprotective agent Substances 0.000 claims description 2
- 230000003394 haemopoietic effect Effects 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims description 2
- 229960001008 heparin sodium Drugs 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 239000012679 serum free medium Substances 0.000 claims description 2
- 230000001502 supplementing effect Effects 0.000 claims description 2
- 238000002826 magnetic-activated cell sorting Methods 0.000 claims 3
- 230000010307 cell transformation Effects 0.000 claims 1
- 239000001963 growth medium Substances 0.000 abstract description 6
- 230000004069 differentiation Effects 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 239000004017 serum-free culture medium Substances 0.000 abstract description 2
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 210000000601 blood cell Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000011134 hematopoietic stem cell transplantation Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 208000009329 Graft vs Host Disease Diseases 0.000 description 2
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 2
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 208000024908 graft versus host disease Diseases 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000003169 placental effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 1
- 206010021450 Immunodeficiency congenital Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000003611 congenital autoimmune diabetes mellitus Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005206 flow analysis Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 210000000066 myeloid cell Anatomy 0.000 description 1
- 230000008672 reprogramming Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
Abstract
Description
Claims (6)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811084025.9A CN109207427B (zh) | 2018-09-17 | 2018-09-17 | 一种将人造血祖细胞转变为造血干细胞的方法 |
CN201980001861.2A CN110799641B (zh) | 2018-04-13 | 2019-04-09 | 丁酸钠的用途及含有丁酸钠的培养体系 |
PCT/CN2019/081854 WO2019196816A1 (zh) | 2018-04-13 | 2019-04-09 | 丁酸钠的用途及含有丁酸钠的培养体系 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811084025.9A CN109207427B (zh) | 2018-09-17 | 2018-09-17 | 一种将人造血祖细胞转变为造血干细胞的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109207427A CN109207427A (zh) | 2019-01-15 |
CN109207427B true CN109207427B (zh) | 2020-12-08 |
Family
ID=64984728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811084025.9A Active CN109207427B (zh) | 2018-04-13 | 2018-09-17 | 一种将人造血祖细胞转变为造血干细胞的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109207427B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110799641B (zh) * | 2018-04-13 | 2021-02-19 | 诺未科技(北京)有限公司 | 丁酸钠的用途及含有丁酸钠的培养体系 |
CN110669732B (zh) * | 2019-11-05 | 2021-05-04 | 清华大学 | 组合物在将造血祖细胞重编程为造血干细胞中的用途 |
CN110804591B (zh) * | 2019-11-07 | 2021-07-09 | 浙江大学 | 含聚合物微纳小球的造血干细胞体外培养体系及应用 |
CN113881633B (zh) * | 2021-12-06 | 2022-02-22 | 山东省齐鲁干细胞工程有限公司 | 一种脐带血造血干细胞体外干性扩增的培养基及方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102011532B1 (ko) * | 2011-09-30 | 2019-08-16 | 블루버드 바이오, 인코포레이티드. | 개선된 바이러스 형질도입을 위한 화합물 |
US20170173083A1 (en) * | 2014-03-26 | 2017-06-22 | The Brigham And Women's Hospital, Inc. | Compositions and methods for ex vivo expansion of human hematopoietic stem/progenitor cells |
CN104845934B (zh) * | 2015-06-08 | 2018-05-11 | 河北彤苓榕生物科技有限公司 | 脐血cd34+造血干细胞来源树突状细胞的大批量制备方法 |
-
2018
- 2018-09-17 CN CN201811084025.9A patent/CN109207427B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN109207427A (zh) | 2019-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109207427B (zh) | 一种将人造血祖细胞转变为造血干细胞的方法 | |
CN112251406B (zh) | 一种nk细胞活化阶段的外泌体分选方法 | |
CN104845934B (zh) | 脐血cd34+造血干细胞来源树突状细胞的大批量制备方法 | |
EP2970913B1 (en) | Cells, methods and apparatuses for umbilical cord blood collection and isolation of cells | |
CN107349219B (zh) | 调节性t细胞在制备治疗免疫糖尿病药物中的应用、及其扩培液和扩培方法 | |
CN109207426B (zh) | 一种将人造血祖细胞转变为造血干细胞的方法 | |
CN112608896A (zh) | 一种nk细胞的培养方法及其应用 | |
CN104877965A (zh) | 一种制备成熟红细胞的方法 | |
CN109706119B (zh) | 扩增造血干细胞的培养体系、方法及其用途 | |
CN109453198A (zh) | 移植物抗宿主疾病的治疗或预防方法 | |
CN111548994B (zh) | 一种细胞培养基及其培养nk细胞的方法 | |
CN111235100B (zh) | 一种人脐带血间充质干细胞的培养方法 | |
CN110799641B (zh) | 丁酸钠的用途及含有丁酸钠的培养体系 | |
CN112251405A (zh) | 一种体外高效诱导扩增nk细胞的方法 | |
CN110055219B (zh) | 一种利用非动员外周血制备异质性造血干祖细胞的方法 | |
CN114058584B (zh) | 一种临床用自然杀伤细胞的制备方法 | |
CN115340981A (zh) | 用于脐带血cd34阳性造血干细胞体外扩增的培养基 | |
CN114438028B (zh) | 一种体外扩增外周血nk的方法 | |
CN108148805B (zh) | 一种人Tscm细胞及其制备方法和应用 | |
CN114807031A (zh) | 一种人外周血免疫细胞库和干细胞库的构建方法 | |
CN110972481B (zh) | 一种组合物及其用途 | |
CN110438081B (zh) | 人套细胞淋巴瘤恶性克隆细胞株及其建立方法和应用 | |
CN114480279A (zh) | 一种高效的人类血液免疫细胞cd4t分离培养技术 | |
CN111154721A (zh) | Nk细胞扩增方法 | |
CN109182268B (zh) | 脐动脉内皮细胞在构建造血干细胞微环境中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20191107 Address after: 100176 Beijing Daxing District economic and Technological Development Zone, 18 South West Road, block B, 1 floor, 103 room. Applicant after: NEWISH TECHNOLOGY (BEIJING) Co.,Ltd. Address before: Room 103, 1st Floor, Block B, 18 West Ring South Road, Daxing Economic and Technological Development Zone, Beijing 100022 Applicant before: NEWISH TECHNOLOGY (BEIJING) Co.,Ltd. Applicant before: NEWISH TECHNOLOGY (YINCHUAN) Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200804 Address after: Building 25, block B, Greenland 21, Xingyuan Road, Xingqing District, Yinchuan City, Ningxia Hui Autonomous Region, 750004 Applicant after: NEWISH TECHNOLOGY (YINCHUAN) Co.,Ltd. Address before: 100176 Beijing Daxing District economic and Technological Development Zone, 18 South West Road, block B, 1 floor, 103 room. Applicant before: NEWISH TECHNOLOGY (BEIJING) Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210508 Address after: 071000 West Unit 3 Floor, Building 12, Zhongguancun Innovation Base, 369 Huiyang Street, Baoding City, Hebei Province Patentee after: Baoding Norway Technology Co.,Ltd. Address before: 750004 building 25, block B, Greenland 21, Xingyuan Road, Xingqing District, Yinchuan City, Ningxia Hui Autonomous Region Patentee before: NEWISH TECHNOLOGY (YINCHUAN) Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Defang Inventor after: Yang Huan Inventor after: Guo Xiao Inventor after: Qi Hailong Inventor after: Wang Xiaofang Inventor before: Liu Defang Inventor before: Chen Ligong Inventor before: Yang Huan Inventor before: Guo Xiao Inventor before: Qi Hailong Inventor before: Wang Xiaofang |
|
CB03 | Change of inventor or designer information |